Corcept Therapeutics (CORT) Capital Expenditures (2012 - 2026)
Corcept Therapeutics (CORT) reported Capital Expenditures of $201000.0 for Q1 2026, up 93.27% on a YoY basis from $104000.0 in Q1 2025, and up 302.0% sequentially from $50000.0 in Q4 2025.
Corcept Therapeutics (CORT) Capital Expenditures (2012 - 2026) Analysis & Trends
Corcept Therapeutics (CORT) has 15 years of Capital Expenditures data on file, last reported at $201000.0 in Q1 2026.
- For the quarter ending Q1 2026, Capital Expenditures rose 93.27% year-over-year to $201000.0; the trailing twelve-month figure through Mar 2026 stood at $308000.0 (down 86.47% YoY), and the FY2025 full-year result was $211000.0, down 90.29% from the prior year.
- Capital Expenditures grew to $201000.0 in Q1 2026, from $50000.0 in the prior quarter.
- In the past five years, Capital Expenditures ranged from a high of $1.6 million in Q3 2024 to a low of $12000.0 in Q1 2022.
- A 5-year average of $241230.8 and a median of $102000.0 in 2023 frame the typical range for Capital Expenditures.
- Across the five-year window, Capital Expenditures slumped 90.48% in 2022 and soared 4318.92% in 2024, its largest moves.
- Tracing CORT's Capital Expenditures over 5 years: stood at $31000.0 in 2022, then rose by 19.35% to $37000.0 in 2023, then jumped by 227.03% to $121000.0 in 2024, then slumped by 58.68% to $50000.0 in 2025, then soared by 302.0% to $201000.0 in 2026.
- Business Quant data shows CORT's Capital Expenditures at $201000.0 in Q1 2026, $50000.0 in Q4 2025, and $57000.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capital Expenditures (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | -8,939.03 |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 43.25 Mn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 133.40 Mn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 230.60 Mn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | 786,000.00 |
| 10 | Corcept Therapeutics | 9.99 Bn | 9.65 Bn | 162.02 Mn | 201,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 201,000.00 |
| Mar 31, 2026 | 201,000.00 |
| Dec 31, 2025 | 50,000.00 |
| Dec 31, 2025 | 50,000.00 |
| Jun 30, 2025 | 57,000.00 |
| Jun 30, 2025 | 57,000.00 |
| Mar 31, 2025 | 104,000.00 |
| Mar 31, 2025 | 104,000.00 |
| Dec 31, 2024 | 121,000.00 |
| Dec 31, 2024 | 121,000.00 |
| Sep 30, 2024 | 1.64 Mn |
| Sep 30, 2024 | 1.64 Mn |
| Jun 30, 2024 | 416,000.00 |
| Jun 30, 2024 | 416,000.00 |
| Sep 30, 2023 | 37,000.00 |
| Sep 30, 2023 | 37,000.00 |
| Jun 30, 2023 | 102,000.00 |
| Jun 30, 2023 | 102,000.00 |
| Dec 31, 2022 | 31,000.00 |
| Dec 31, 2022 | 31,000.00 |